Clinical pharmacology of tobramycin in newborns.

Tobramycin is a new aminoglycoside antibiotic with activity against a wide range of bacteria. More than 90% of coliform organisms andPseudomonaswere susceptible in vitro to 5μg/ml of tobramycin. Pharmacokinetic properties of tobramycin in neonates are similar to those of gentamicin. Peak levels of 4μg to 6μg/ml are achieved in serum after a dose of 2.0 mg/kg; it can be given every 12 hours for up to ten days without accumulation. Serum half-life values were inversely related to birth weights and creatinine clearances. It is suggested that tobramycin be used only for the treatment of neonatal infections caused by tobramycin-susceptible gram-negative organisms resistant to both kanamycin and gentamicin. Studies of clinical efficacy and toxicity in neonates are necessary before the drug can be recommended for routine use.

[1]  S. Davis,et al.  Antagonistic Effect of Calcium in Serum on the Activity of Tobramycin Against Pseudomonas , 1972, Antimicrobial Agents and Chemotherapy.

[2]  W. Farrar,et al.  Tobramycin: In Vitro Activity and Comparison with Kanamycin and Gentamicin , 1972, Antimicrobial Agents and Chemotherapy.

[3]  J. Weinstein,et al.  Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety. , 1972, Biochemistry.

[4]  D. Gilbert,et al.  Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin. , 1971, The Journal of infectious diseases.

[5]  G. Mccracken.  Changing pattern of the antimicrobial susceptibilities of Escherichia coli in neonatal infections. , 1971, The Journal of pediatrics.

[6]  J. Davies,et al.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor. , 1971, Biochemistry.

[7]  G. Mccracken,et al.  Urinary excretion of gentamicin in the neonatal period. , 1971, The Journal of infectious diseases.

[8]  L. G. Jones,et al.  Gentamicin in the neonatal period. , 1970, American journal of diseases of children.

[9]  H. Simon,et al.  Microbioassay of antimicrobial agents. , 1970, Applied microbiology.

[10]  S. G. Axline,et al.  CLINICAL PHARMACOLOGY OF KANAMYCIN IN PREMATURE INFANTS * , 1966, Annals of the New York Academy of Sciences.

[11]  H. Eichenwald.  SOME OBSERVATIONS ON DOSAGE AND TOXICITY OF KANAMYCIN IN PREMATURE AND FULL‐TERM INFANTS * , 1966, Annals of the New York Academy of Sciences.

[12]  E. Steers,et al.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. , 1959, Antibiotics & chemotherapy.

[13]  W. Traub,et al.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. , 1972, Applied microbiology.

[14]  B. Calesnick,et al.  PHARMACOLOGY OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC. , 1963, Antimicrobial agents and chemotherapy.